$ECHO

Wade William David sold $460K of ECHO

Wade William David sold 5,000 shares of EchoStar CORP (ECHO) at an average of $92.08 ($91.48–$92.65, $0.46M total) across 2 trades over 2026-08-12 to 2026-08-13.

Original reporting
SEC EDGAR · Wade William David
Published Aug 14, 2026, 10:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 10:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ECHO
Neutral
medium confidence
Mentioned
$ECHO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECHONeutralLow
01

Why it matters

The newest information is the specific sale quantity, price range, and post-transaction holdings. It is not accompanied by any operational or financial guidance change.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive a fundamental repricing.

03

What to watch

Insider sales are often driven by diversification, taxes, or pre-existing personal liquidity needs; the filing does not indicate any change in company outlook.

Relevance 4/10Novelty 5/10Timing: filed 2026-08-14 after-hours; sale executed 2026-08-12 to 2026-08-13

Background

The article is a SEC Form 4 insider transaction disclosure for EchoStar, reported by a director.

Company-level read

Ticker impact

$ECHONeutralMedium confidence
Context

EchoStar director Wade William David sold about 5,000 shares in open-market transactions for roughly $460K, per a newly filed Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider transaction, not an earnings, guidance, or operational update. The article provides sale size, dates, and price range, but no new company-specific catalyst.

Market effects

No clear sector read-through from a single director’s open-market sale.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as discretionary selling, which some traders may read as near-term caution.

Key entities

  • EchoStar CORP

    Subject of the Form 4 insider transaction disclosure.

  • Wade William David

    Director who sold shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WMGMed

Morgan Stanley Names Some Of Its Buys as Wall Street Spots Opportunity in Beaten-Down Stocks

Morgan Stanley identified Warner Music Group, Darden Restaurants, SiTime, and EchoStar as attractive investment opportunities. Analysts highlighted Warner Music's catalog value (> $30 per share) and strong Q3 results (revenue $1.86B, up 10%). Darden's price target was raised to $255. EchoStar was noted for its SpaceX exposure and spectrum holdings. SiTime was also recommended.

$AAPLMed

Apple, Compass Pathways, Aritzia and more analyst calls of the week

Dell shares rose 11% to a record high after RBC initiated coverage with an Outperform rating and $640 target, citing strong AI and PC demand. Apple shares gained 3.1% after unveiling its first foldable iPhone, the iPhone Duo, priced at $1,999 and above. AstraZeneca's shares remained flat despite mixed analyst views on its drug tozorakimab. Compass Pathways shares climbed 4% on positive Phase III study data for its psilocybin treatment.